San Francisco, California, January 7-9, 2013 —
Virovek presented its newest patented technology to manufacture AAV vectors harboring toxins, the first of its kind, at the Biotech Showcase 2013 where private and small- and mid-cap biotechnology companies present their innovations to investors and bio-pharmaceutical executives.